Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Ionis Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Ionis Pharmaceuticals Inc
Rating: 0.954250125
Author: Trendlyne DVM scores

Momentum Trap

about

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

74.12 -0.19 (-0.26%)

100.70% Gain from 52W Low

3.0M

XNAS Volume

XNAS 18 Jun, 2026 5:30 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

7.7 / 100

Technically Neutral

35.3 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

105

1Yr Price target upside is 42%

23 analysts

Ionis Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

100.70% Gain from 52W Low

SWOT Analysis

Ionis Pharma Inc Live Price Chart